Early morphological change for predicting outcome in metastatic colorectal cancer after regorafenib

BACKGROUND AND OBJECTIVE: It is unclear whether early morphological change (EMC) is a predictive marker for regorafenib in metastatic colorectal cancer (mCRC). Therefore, the present study investigated whether EMC can predict the outcome of mCRC patients receiving regorafenib. RESULTS: This study ev...

Descripción completa

Detalles Bibliográficos
Autores principales: Arai, Hiroyuki, Miyakawa, Kunihisa, Denda, Tadamichi, Mizukami, Takuro, Horie, Yoshiki, Izawa, Naoki, Hirakawa, Mami, Ogura, Takashi, Tsuda, Takashi, Sunakawa, Yu, Nakajima, Takako Eguchi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5746401/
https://www.ncbi.nlm.nih.gov/pubmed/29299166
http://dx.doi.org/10.18632/oncotarget.22807

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5746401/
https://www.ncbi.nlm.nih.gov/pubmed/29299166
http://dx.doi.org/10.18632/oncotarget.22807

Ejemplares similares